Why the study?
Does elevated admission HbA1c level predict short- and long-term mortality in patients with STEMI?
Population
19 prospective studies involving a total of 35,994 patients diagnosed with ST-segment elevation myocardial…
Comparison
Elevated admission glycated hemoglobin level vs Lower or normal admission glycated hemoglobin…
Design
Meta-analysis
Follow-up
in-hospital, 30-day, and long-term
Authors
Loading...
May refine STEMI risk stratification; extends observational evidence on chronic hyperglycemia but leaves causality and practice change open.
Does elevated admission HbA1c level predict short- and long-term mortality in patients with STEMI?
Elevated admission HbA1c in STEMI patients is a significant predictor of 30-day and long-term mortality, highlighting the prognostic importance of chronic glucose dysregulation in this population.
Li et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: